A Study of Fisetin to Treat Carpal Tunnel Syndrome
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This research study is being conducted to investigate the safety and effectiveness of the
drug Fisetin for mild or moderate carpal tunnel syndrome (CTS).